| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 10/14/1999 | CA2325353A1 Enhancement of cellular gallium uptake |
| 10/14/1999 | CA2323440A1 Radioactivable composition suitable for fabrication of implantable medical devices |
| 10/13/1999 | EP0949632A2 Method for preparing (F-18)-fluoride ion. |
| 10/13/1999 | EP0949265A1 Radioactive transition metal nitride hetero-complex |
| 10/13/1999 | EP0692977B1 Novel heterocycle based nitrogen-sulfur ligands useful in radiographic imaging agents |
| 10/12/1999 | US5965383 Fibrin binding domain polypeptides and uses and methods of producing same |
| 10/12/1999 | US5965359 Mixing cells from biological sample with detectable labeled complementary dna probe, detecting the presence of the probe that hybridizes with messenger rna for human platelet-derived growth factor receptor gene |
| 10/12/1999 | US5965133 Self-assembling multimeric nucleic acid constructs |
| 10/12/1999 | US5965132 Methods and compositions for targeting the vasculature of solid tumors |
| 10/12/1999 | US5965131 Galactosylated clearing agent binds to the primary binding site of the primary targeting species, and only non-bound primary targeting species is cleared, not bound species second site is not blocked by the clearing agent |
| 10/12/1999 | US5965108 Cyclic peptide-metal complex specifically binds to surface somatostatin receptor-expressing cells; radiology; scintigraphy; antitumor,-carcinogenic and metastatic agents; stability |
| 10/12/1999 | US5965107 Electrically neutral complex comprising radioactive technetium, peptide, radiolabel binding moiety; radiolabelled peptide for medical diagnostic imaging |
| 10/12/1999 | US5965106 In vivo binding pair pretargeting |
| 10/12/1999 | CA2033995C Nuclear imaging uses of radio-labelled atrial natriuretic factor |
| 10/07/1999 | WO1999049931A2 Bismuth-213 generator and uses thereof |
| 10/07/1999 | WO1999049901A1 Water soluble paclitaxel derivatives |
| 10/07/1999 | WO1999049900A1 Tumour imaging and therapeutic agents |
| 10/07/1999 | WO1999049899A2 Diagnostic imaging of vascular abnormalities using vasomodification |
| 10/07/1999 | CA2731416A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 10/06/1999 | EP0946526A1 Macrocyclic metal complex carboxylic acids, use and method for the production thereof |
| 10/06/1999 | EP0946510A1 Novel compounds with analgesic effect |
| 10/06/1999 | EP0946205A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them |
| 10/06/1999 | EP0946204A1 Process for the preparation of radiopharmaceuticals |
| 10/06/1999 | EP0946202A2 Contrast agents |
| 10/06/1999 | EP0779933A4 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 10/06/1999 | CN1230891A Lectin compositions and uses thereof |
| 10/06/1999 | CN1230406A Application of benzoic benzylamine amide as bitter agent |
| 10/05/1999 | US5962424 Inducing selectin expression using ionizing radiation |
| 10/05/1999 | US5962409 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone |
| 10/05/1999 | US5962335 Determining theraputic dosage regimen of drug by labeling drug with endogenous non-radioactive isotope and measuring isotope concentration before and after administration of drug; difference in values provides metabolism information |
| 10/05/1999 | US5962220 St receptor binding moieties bind to the st receptor which is found on human colon cells. the invention relates to antisense compositions specifically targeted to colon cells. |
| 10/05/1999 | US5961955 Radioprotectant for peptides labeled with radioisotope |
| 10/05/1999 | US5961954 Chealators of type XN1 S1 X1 for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses |
| 10/05/1999 | US5961952 99m Tc-tertiary-butyl isonitrile as breast tumor imaging agents |
| 09/30/1999 | WO1999048536A2 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo |
| 09/30/1999 | WO1999039765A3 Soft x-ray emitting medical devices |
| 09/30/1999 | WO1999034838A3 Nuclear scintigraphic assessment of mucosal function |
| 09/30/1999 | DE19813687A1 New radioimmunoconjugate, useful for treating hematopoietic diseases, solid tumors and their metastases and inflammatory diseases |
| 09/30/1999 | CA2291066A1 Local delivery of long lasting therapeutic agents |
| 09/29/1999 | EP0944626A1 Tropane derivatives and method for their synthesis |
| 09/29/1999 | CN1045290C Method for preparation of chelans possesing ortho ligating functionality and complexes |
| 09/28/1999 | US5958881 Comprising peptide having amino acid sequence of vasoactive intestinal peptide; for inducing temporary substantial paralysis an area of interest in patients undergoing endoscopy or other medical procedure; side effect reduction |
| 09/28/1999 | US5958770 Glycoalkaloids |
| 09/28/1999 | US5958412 Administering conjugate of antibody and anti-cancer drug, where in antibody is specific for a33 antigen for promoting colon or gastric cancer regression |
| 09/28/1999 | US5958408 Glycosylation of lysin residue of a clearing agent which is an antibody or an antigen binding fragment of an antibody with a galactose residue for achieving fast clearance |
| 09/28/1999 | US5958398 Biodegradable polyacetal polymers and methods for their formation and use |
| 09/28/1999 | US5958374 Method for preparing radionuclide-labeled chelating agent-ligand complexes |
| 09/28/1999 | US5958372 Low viscosity chelating polymers for diagnostic imaging |
| 09/28/1999 | US5958371 Site specific binding system, nuclear imaging compositions and methods |
| 09/22/1999 | EP0942996A1 Thrombolytic agents with antithrombotic activity |
| 09/22/1999 | EP0942757A2 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof |
| 09/22/1999 | EP0942741A1 Lectin compositions and uses thereof |
| 09/22/1999 | EP0663900B1 Metal-oxime chelates for use as radiopharmaceutical agents |
| 09/22/1999 | EP0562054B1 Transition metal complex for use as a diagnostic or therapeutic pharmaceutical |
| 09/22/1999 | CN1229436A Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 09/21/1999 | US5955605 Biotinidase resistant biotin-DOTA conjugates |
| 09/21/1999 | US5955603 Porphyrins and porphyrin synthesis techniques |
| 09/21/1999 | US5955472 Naphthylazo inhibition of amyloidosis |
| 09/21/1999 | US5955437 Use of an anticoagulant as a diagnostic agent |
| 09/21/1999 | US5955426 Such peptides radiolabeled with a radiosiotope, as well as methods for using such peptides for radiodiagnostic and radiotherapeutic purposes |
| 09/21/1999 | US5955055 Detection accumulated peptide with amino acid sequence region of apolipoprotein or elastin; labelling; diagnosing atherosclerosis |
| 09/21/1999 | US5955054 Composition for detection of helicobacterium pylori that causes ulcers |
| 09/21/1999 | US5955053 Metal chelates as pharmaceutical imaging agents, processes of making such and uses thereof |
| 09/16/1999 | WO1999045970A1 Multicomponent complex for use with a substrate |
| 09/16/1999 | WO1999045969A2 Radioimmuno-pharmacon for treating the hiv-1 infection |
| 09/16/1999 | CA2323016A1 Multicomponent complex for use with a substrate |
| 09/15/1999 | EP0941124A1 Antisense oligonucleotide compositions for selectively killing cancer cells |
| 09/14/1999 | US5952464 Oligopeptide with selective neurotensin receptor affinity labelled with metal isotope or radioactive halogen isotope; for diagnostic imaging and anticarcinogenic agents |
| 09/14/1999 | US5952336 Antifertility agents, contraceptives |
| 09/14/1999 | US5951981 Thrombolytic agents with antithrombotic activity |
| 09/14/1999 | US5951964 Technetium-99m labeled peptides for imaging |
| 09/14/1999 | CA1340741C Cloned genes encoding ig-cd4 fusion protiens and the use thereof |
| 09/10/1999 | WO1999044646A1 Novel imaging agents and methods for the preparation and use thereof |
| 09/10/1999 | WO1999044645A1 Compositions and methods of treating tumors |
| 09/10/1999 | WO1999025666A3 Process for the selective oxidation of organic compounds |
| 09/10/1999 | CA2322592A1 Use of a peptide or antibody in the manufacture of a medicament for treating an erbb protein medicated tumor in combination with irradiation |
| 09/09/1999 | DE19809785A1 Radioimmune conjugate based on monoclonal antibody for HIV treatment |
| 09/08/1999 | EP0939809A2 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
| 09/08/1999 | EP0637968B1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
| 09/07/1999 | US5948933 Tropane analogs and methods for inhibition of monoamine transport |
| 09/07/1999 | US5948386 Conjugate and method for forming aminomethyl phosphorus conjugates |
| 09/07/1999 | US5948384 Particulate agents |
| 09/07/1999 | US5947889 Balloon catheter used to prevent re-stenosis after angioplasty and process for producing a balloon catheter |
| 09/02/1999 | WO1999043817A1 High affinity humanized anti-cea monoclonal antibodies |
| 09/02/1999 | WO1999043816A1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 09/02/1999 | WO1999043317A1 Necrosis-affine compounds and the utilization thereof in order to produce preparations for pharmacotherapy |
| 09/02/1999 | CA2321947A1 High affinity humanized anti-cea monoclonal antibodies |
| 09/02/1999 | CA2321932A1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 09/01/1999 | EP0938905A1 Method of affixing radioisotopes onto stents, medical devices, implants and sources |
| 09/01/1999 | EP0650475B1 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides, their preparation and their use as 5-ht2 antagonists |
| 09/01/1999 | EP0573545B1 Monoclonal antibodies against receptor-induced binding sites |
| 09/01/1999 | CN1227603A TIE-2 receptor ligands (TIE ligand-3; TIE ligand-4) and their uses |
| 08/31/1999 | US5944670 Chlmydia |
| 08/26/1999 | WO1999042177A1 Radioactive stent |
| 08/26/1999 | WO1999042163A1 Thin film radiation source |
| 08/26/1999 | DE19824653A1 Use of compounds concentrating in necrotic tissue as drug depots, e.g. for radiation therapy, pharmacotherapy, restenosis prevention and diagnosis |
| 08/26/1999 | CA2320986A1 Thin film radiation source |
| 08/26/1999 | CA2320982A1 Radioactive stent |
| 08/25/1999 | CN1226825A Use of amines to produce drugs for preventing tumour cell proliferation |
| 08/24/1999 | US5942496 Methods and compositions for multiple gene transfer into bone cells |